Flowpoint Bio, Inc.

Overview

FlowPoint Bio is developing high-viability nuclear delivery for next-generation cell and gene therapies.

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing instruments and instrumentation systems for laboratory analysis of the chemical or physical composition or concentration of samples of solid, fluid, gaseous, or composite material.

1. Manufacturing33
2. Computer and Electronic Product Manufacturing334
3. Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
4. Analytical Laboratory Instrument Manufacturing334516

Capabilities